Assignee
SHAANXI PANLONG PHARMACEUTICAL CO LTD
CN·5 granted patents·1 pending application·9 citations·filing 2022–2023
Top patents by PatentIndex Score
6 records- 0191US11530195B1Protacs targeting coronavirus 3CL protease and preparation method and application thereofSHAANXI PANLONG PHARMACEUTICAL CO LTD·Filed 2022·Granted Dec 20, 2022·5 cites·5 claims
- 0289US11518759B1Protacs based on VHL ligand targeting coronavirus 3CL protease and preparation method and application thereofSHAANXI PANLONG PHARMACEUTICAL CO LTD·Filed 2022·Granted Dec 6, 2022·2 cites·4 claims
- 0388US11612603B13-triazolyl methyl-1,3,5-triazine-2,4-dione compounds and preparation method and application thereofSHAANXI PANLONG PHARMACEUTICAL CO LTD·Filed 2022·Granted Mar 28, 2023·2 cites·2 claims
- 0459US12221424B23-tetrazolylmethyl-1,3,5-triazin-2,4-dione compound inhibiting coronavirus 3CL protease activity and preparation method and use thereofSHAANXI PANLONG PHARMACEUTICAL CO LTD·Filed 2023·Granted Feb 11, 2025·0 cites·4 claims
- 0558US2024074990A1Application of gossypol and its optical isomers to preparation of coronavirus 3cl protease inhibitorSHAANXI PANLONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0656US12201665B2Polygoni Milletii Rhizome compositions and methods of preparing the sameSHAANXI PANLONG PHARMACEUTICAL CO LTD·Filed 2022·Granted Jan 21, 2025·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when SHAANXI PANLONG PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →